Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients.
Saved in:
| Title: | Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients. |
|---|---|
| Authors: | Seery T; Chan Soon-Shiong Institute for Medicine, El Segundo, CA, United States., Sender L; ImmunityBio Inc., Culver City, CA, United States., Jafari O; Medical Imaging Center of Southern California, Santa Monica, CA, United States., Jones F; NantCell, Culver City, CA, United States., Spilman P; ImmunityBio Inc., Culver City, CA, United States., Reddy SB; ImmunityBio Inc., Culver City, CA, United States., Soon-Shiong P; ImmunityBio Inc., Culver City, CA, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Jan 29; Vol. 15, pp. 1472714. Date of Electronic Publication: 2025 Jan 29 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1472714 |
